21 September 2020 in IEEE Access
Due to the availability of fingerprint verification technology on mobile devices fingerprint based human identification has become the most widely used biometric technology in everyday life. The elderly find digital payment applications difficult to operate and unsecure. This work has exploited fingerprint verification availability on mobile devices to provide a user friendly and secure digital wallet payment facility to elderly who are unable to avail this facility due to the complex infrastructure of traditional authentication mechanisms. A novel digital payment mechanism is presented which uses Bluetooth technology of mobile devices for billing at the point of sale and fingerprint verification for user authentication. A proof of the concept study is presented to validate the proposed model using state of the art usability questionnaires and attributes with the target group. The result indicates that the proposed methodology provides satisfaction and ease of use to the user.
11 May 2018 in Catalysis Science & Technology
In this study, we examine autoxidation and its role on the catalytic aerobic oxidation of cinnamyl alcohol using supported AuPd nanoparticles. We further report the crucial role of reaction conditions in the reaction pathway. Close attention is paid to the mechanism of the formation of benzaldehyde, a by-product formed in large quantities from the process of autoxidation. The activity of the catalysts depends on the preparation method with different sizes of nanoparticles obtained by the two methods of preparation. The catalysts can inhibit the autoxidation process or the two processes, namely catalytic oxidation and autoxidation, can coexist. In the case of oxidation of cinnamyl alcohol, 0.5%(wt) Au–0.5%(wt) Pd/TiO2 catalysts prepared by various methods allow different product distributions to be obtained. The catalyst prepared by the sol-immobilisation method seems to prevent autoxidation, leaving the catalytic process dominant. Catalysts prepared by the impregnation method seem to enable both the catalytic process and autoxidation to occur at the same time. We show that using the optimum catalyst for this reaction, the autoxidation process can be mitigated.
2 January 2018 in Catalysis, Structure & Reactivity
We have investigated xNi–yCu–ZrO2 catalysts for the selective synthesis of γ-valerolactone from levulinic acid (LA). A series of xNi–yCu–ZrO2 catalysts with a consistent metal loading of 50% but varying Ni and Cu composition were prepared by an oxalate gel precipitation method and tested for LA hydrogenation. Ni-rich catalysts showed higher catalytic activity compared with Cu-rich formulations with a 45Ni–5Cu–ZrO2 composition yielding 76% γ-valerolactone after a reaction time of 30 min at 200 °C. Characterisation of the materials by XRD, surface area measurements and TPR allow us to attribute the differences in performance seen for different compositions to particle size and nanoparticle dispersion effects. DFT calculations also showed that a shift of d-band centre to higher energies with the mole fraction of Ni in Cu–Ni alloys would be expected to lead to improved hydrogen dissociation in Ni-rich catalysts and so aid hydrogenation activity.
2 February 2018 in Journal of the College of Physicians and Surgeons Pakistan
MYMuhammad Iftikhar Yousaf Iftikhar Yousaf
Muhammad Iftikhar Yousaf Iftikhar Yousaf
To determine frequency and pattern of adverse events reporting in a subset of Pakistani population being treated for chronic hepatitis C with sofosbuvir combination therapy. Descriptive study. Department of Medicine, Gastroenterology Division, Shalamar Hospital, Lahore, from September 2015 to May 2016. Patients who were offered sofosbuvir therapy for treatment of chronic hepatitis C were randomly enrolled. The study subset included both treatment nave as well as retreatment groups. Patients were screened for subjective as well as objective evidence of adverse events at regular intervals. Frequency was determined. Among 196 patients with chronic hepatitis C, 192 patients received dual therapy consisting of ribavirin and sofosbuvir. The most frequent complaints in these subjects were fatigue, fever, myalgias and nausea accounting for 55%, 42%, 44.2% and 50%, respectively. Twenty-seven percent of patients reported with drop in hemoglobin of >2g/dl, while absolute neutropenia and moderate to severe thrombocytopenia was observed in 3% and 5% of patients, respectively. One patient died as a result of severe pancytopenia. Later derangements were all observed in patients with decompensated disease. Sofosbuvir showed less severe adverse effects in terms of symptomatology and less frequent neutropenia and thrombocytopenia as compared to previous regimens. Careful monitoring is required, especially in those with decompensated liver disease.